ILC1: guardians of the oral mucosa against enemy viruses

Type 1 innate lymphoid cells (ILC1s) regulate inflammation in the tissues; however, their role in anti-viral immunity remains largely unknown. In this issue of Immunity, Shannon et al. report that ILC1s invoke an anti-viral effect by producing interferon (IFN)γ at homeostasis, thereby limiting viral...

Descripción completa

Detalles Bibliográficos
Autores principales: Nabekura, Tsukasa, Shibuya, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Preview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871888/
https://www.ncbi.nlm.nih.gov/pubmed/33567258
http://dx.doi.org/10.1016/j.immuni.2021.01.002
_version_ 1783649101876822016
author Nabekura, Tsukasa
Shibuya, Akira
author_facet Nabekura, Tsukasa
Shibuya, Akira
author_sort Nabekura, Tsukasa
collection PubMed
description Type 1 innate lymphoid cells (ILC1s) regulate inflammation in the tissues; however, their role in anti-viral immunity remains largely unknown. In this issue of Immunity, Shannon et al. report that ILC1s invoke an anti-viral effect by producing interferon (IFN)γ at homeostasis, thereby limiting viral replication in the oral mucosa.
format Online
Article
Text
id pubmed-7871888
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-78718882021-02-10 ILC1: guardians of the oral mucosa against enemy viruses Nabekura, Tsukasa Shibuya, Akira Immunity Preview Type 1 innate lymphoid cells (ILC1s) regulate inflammation in the tissues; however, their role in anti-viral immunity remains largely unknown. In this issue of Immunity, Shannon et al. report that ILC1s invoke an anti-viral effect by producing interferon (IFN)γ at homeostasis, thereby limiting viral replication in the oral mucosa. Elsevier Inc. 2021-02-09 2021-02-09 /pmc/articles/PMC7871888/ /pubmed/33567258 http://dx.doi.org/10.1016/j.immuni.2021.01.002 Text en © 2021 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Preview
Nabekura, Tsukasa
Shibuya, Akira
ILC1: guardians of the oral mucosa against enemy viruses
title ILC1: guardians of the oral mucosa against enemy viruses
title_full ILC1: guardians of the oral mucosa against enemy viruses
title_fullStr ILC1: guardians of the oral mucosa against enemy viruses
title_full_unstemmed ILC1: guardians of the oral mucosa against enemy viruses
title_short ILC1: guardians of the oral mucosa against enemy viruses
title_sort ilc1: guardians of the oral mucosa against enemy viruses
topic Preview
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871888/
https://www.ncbi.nlm.nih.gov/pubmed/33567258
http://dx.doi.org/10.1016/j.immuni.2021.01.002
work_keys_str_mv AT nabekuratsukasa ilc1guardiansoftheoralmucosaagainstenemyviruses
AT shibuyaakira ilc1guardiansoftheoralmucosaagainstenemyviruses

Ejemplares similares